Disease Management

Health Dialog announced Tuesday that it has received Patient Oriented Accreditation from the National Committee for Quality Assurance for its disease management programs for asthma, congestive heart failure, chronic obstructive pulmonary disease, coronary heart disease and diabetes.

NEW YORK — Bristol-Myers Squibb and Nordic Bioscience on Monday announced a collaboration agreement to develop biomarker technology to potentially aid in the diagnosis and monitoring of fibrotic diseases including non-alcoholic steatohepatitis (NASH). A biomarker is a molecule that may be used to diagnose a disease, or predict disease progression and indicate response to therapy.

SAN FRANCISCO  - Fitbit on Monday announced that Adam Pellegrini will join the company as VP digital health, beginning Sept. 6. Pellegrini will be responsible for leading Fitbit’s vision, strategies and programs to further drive the company’s integration into healthcare systems around the world.

As patients look for ways to obtain healthcare in more convenient and lower-cost settings, new opportunities are emerging for retail pharmacies to help meet patient needs. Many pharmacies already are recognized as cost-efficient channels for expanding public access to vaccinations, disease management, medication management, and other clinical services.